Skip to main content

Table 1 The association between prevalent genotypes of human papilloma virus persistent positivity and cervical lesions

From: The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China

HPV persistent infection
Pathological stage No. 15257 HPV + χ 2 P Multiple HPV(+) χ 2 P HPV 16+ χ 2 P HPV 58+ χ 2 P HPV 18+ χ 2 P HPV 52+ χ 2 P HPV 33+ χ 2 P
Stage 1                       
normal 10477 262 519.846 0.0001 98 404.940 0.0001 43 139.334 0.0001 59 494.956 0.0001 83 45.796 0.0001 55 59.537 0.0001 47 94.149 0.0001
CINI 2068 283    162    62    155    51    45    52   
Stage 2                       
CINI 2068 283 2054.183 0.0001 162 107.486 0.0001 62 180.252 0.0001 155 0.444 0.522 51 5.929 0.016 45 4.881 0.031 52 3.019 0.094
CINII/III 1604 1426    311    247    111    62    54    56   
Stage 3                       
CINII/III 1604 1426 0.53 0.5 311 1.245 0.271 247 0.046 0.829 111 0.321 0.571 62 6.374 0.013 54 1.999 0.157 56 0.677 0.378
Cervical cancer 1108 975    196    174    83    66    49    42